+919405117673

Oncology Medicine

Tipanat Tablets – Composition, Strengths, Uses & FAQs

In stock

Description

Product Description of Tipanat Tablets

Tipanat Tablets are an oral prescription medicine containing trifluridine and tipiracil, a combination used in oncology treatment. This medicine is indicated for eligible patients with certain advanced or metastatic colorectal cancer, subject to approved prescribing criteria and medical evaluation.

Tipanat Tablets are intended for use under the supervision of a qualified oncologist. Treatment decisions depend on the patient's diagnosis, previous therapies, general health, laboratory results and the applicable prescribing information. Patients should not start, stop or modify treatment without medical advice.

For healthcare professionals, pharmaceutical distributors and international procurement teams, product verification should include the active ingredients, strength, manufacturer, packaging, batch details, expiry date and applicable regulatory documentation.

Tipanat Tablets Composition and Strengths

Tipanat Tablets are available in different strengths. The commonly listed strengths include:

Tipanat 15 mg/6.14 mg Tablets: Each tablet contains trifluridine 15 mg and tipiracil 6.14 mg.

Tipanat 20 mg/8.19 mg Tablets: Each tablet contains trifluridine 20 mg and tipiracil 8.19 mg.

Always verify the exact composition against the product packaging and approved prescribing information before dispensing or purchasing. Availability, pack sizes and regulatory approvals may vary between countries.

Uses and Medical Information

Tipanat Tablets are used for certain cases of advanced or metastatic colorectal cancer when patients meet the applicable treatment criteria. The active ingredients work together to interfere with cancer-cell growth.

The medicine is not suitable for everyone. An oncologist evaluates its potential benefits, risks, previous treatment history and the patient's clinical condition before prescribing it.

Important Safety Information

Possible adverse effects include fatigue, nausea, diarrhoea, reduced appetite and changes in blood-cell counts. Serious complications can occur, including severe bone marrow suppression and infections.

Regular blood tests and medical monitoring are important during treatment. Patients should inform their healthcare provider about other medicines, existing medical conditions, pregnancy, breastfeeding or plans to conceive. Follow the prescribed schedule and the instructions supplied with the medicine.

Frequently Asked Questions About Tipanat Tablets

1. What are Tipanat Tablets used for?

They are used to treat certain eligible patients with advanced or metastatic colorectal cancer under specialist supervision.

2. What strengths are available?

Commonly listed strengths include 15 mg/6.14 mg and 20 mg/8.19 mg. Confirm current availability and product specifications with an authorised supplier.

3. Can Tipanat Tablets be taken without a prescription?

No. This is a prescription oncology medicine and should only be used under the supervision of a qualified healthcare professional.

4. How should Tipanat Tablets be taken?

Follow the oncologist's instructions and the approved product information. Do not change the dose or schedule independently.

5. Can Tipanat Tablets be purchased internationally?

International supply depends on local medicine regulations, prescription requirements, import permits and product registration. Buyers should verify supplier credentials and destination-country requirements before placing an order.

6. What should buyers check before purchasing?

Confirm the composition, strength, packaging, batch number, expiry date, storage conditions, manufacturer details and required quality and regulatory documents.

Enquiries and Product Verification

For product information or pharmaceutical procurement enquiries, request verified specifications, available pack details and relevant regulatory documentation from a qualified supplier. All supply and distribution must comply with applicable pharmaceutical laws and destination-country requirements.

Medical disclaimer: This page provides general product information and does not replace professional medical advice or approved prescribing information.

Keywords